1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Electrocardiogram QT Prolonged in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berrino, L; D'Amico, M; Di Filippo, C; Giugliano, D; Marfella, R; Rossi, F | 1 |
1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Electrocardiogram QT Prolonged
| Article | Year |
|---|---|
Endothelin-1 receptor antagonists reduce cardiac electrical instability induced by high glucose in rats.
Topics: Animals; Azepines; Dose-Response Relationship, Drug; Electrocardiography; Endothelin Receptor Antagonists; Glucose; Heart; Heart Conduction System; In Vitro Techniques; Indans; Indoles; Long QT Syndrome; Male; Oligopeptides; Piperidines; Rats; Receptor, Endothelin A; Receptors, Endothelin | 2002 |